- Home
- FDMT vs PGC Comparison
FDMT vs PGC Comparison
Compare FDMT & PGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FDMT | PGC |
|---|---|---|
| Founded | 2013 | 1921 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Commercial Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 695.3M | 698.4M |
| IPO Year | 2019 | 1997 |
Fundamental Metrics
Financial Performance| Metric | FDMT | PGC |
|---|---|---|
| Price | $12.92 | $47.39 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 2 |
| Target Price | $31.71 | ★ $40.50 |
| AVG Volume (30 Days) | ★ 1.0M | 164.0K |
| Earning Date | 05-08-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 0.48% |
| EPS Growth | ★ 18.79 | 13.51 |
| EPS | N/A | ★ 0.80 |
| Revenue | $85,209,000.00 | ★ $282,995,000.00 |
| Revenue This Year | N/A | $32.39 |
| Revenue Next Year | $70.28 | $12.64 |
| P/E Ratio | ★ N/A | $59.23 |
| Revenue Growth | ★ 230194.60 | 24.05 |
| 52 Week Low | $4.11 | $24.45 |
| 52 Week High | $14.00 | $49.14 |
Technical Indicators
Market Signals| Indicator | FDMT | PGC |
|---|---|---|
| Relative Strength Index (RSI) | 69.70 | 62.00 |
| Support Level | $8.39 | $43.44 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 1.00 | 1.39 |
| MACD | 0.35 | 0.12 |
| Stochastic Oscillator | 81.66 | 69.13 |
Price Performance
Historical ComparisonAbout FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients. Companies focus is on advancing 4D-150 for wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME) through late-stage studies. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-710 and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector).
About PGC Peapack-Gladstone Financial Corporation
Peapack Gladstone Financial Corp is a bank holding company. Through its subsidiaries, the company offers various wealth management, investment banking, and commercial and personal banking solutions to its clients. The company has two reportable segments: Banking, which generates the maximum revenue, and Wealth Management. The Banking segment includes commercial, commercial real estate, multifamily, residential, and consumer lending activities; treasury management services; escrow management; deposit generation; operation of ATMs; telephone and internet banking services; credit card services, etc. The Wealth Management segment offers investment management services for individuals and institutions; personal trust services; and other financial planning and advisory services.